You watched
Dear buyers! Unfortunately, we are currently unable to accept the application to Canada and are revoking the license. Keep an eye on the site to see if there are any updates from Canada.
Catalog
Client
Currency:
Contacts
Our location:
Ternopil city
Contacts
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
20
Wishlist
0
Compare
0
Contacts

Mircera solution for injection 75 mcg syringe tube 0.3 ml No. 1

SKU: an-38298
0
All about product
Description
Specification
Reviews 0
Questions0
new
Mircera solution for injection 75 mcg syringe tube 0.3 ml No. 1
In Stock
4 393.80 грн.
Active ingredient:Methoxy polyethylene glycol-epoetin beta
ATC code:B AGENTS AFFECTING THE BLOOD SYSTEM AND HEMOPOIESIS; B03 ANTIANEMIQUE AGENTS; B03X OTHER ANTIANEMIQUE PREPARATIONS; B03X A Other antianemic preparations; B03X A03 Methoxypolyethylene glycol-epoetin beta
Country of manufacture:Germany
Dosage:75 mcg
Form:Pre-filled syringes
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Mircera solution for injection 75 mcg syringe tube 0.3 ml No. 1
4 393.80 грн.
Description

Mircera injection solution is used in the treatment of symptomatic anemia associated with chronic kidney disease.

Composition

Active ingredient: methoxy polyethylene glycol-epoetin beta;

1 pre-filled syringe with 0.3 ml solution for injection contains 50 mcg or 75 mcg methoxy polyethylene glycol-epoetin beta;

Excipients: L-methionine; sodium sulfate anhydrous; sodium dihydrogen phosphate monohydrate; mannitol (E 421); poloxamer 188; diluted hydrochloric acid or sodium hydroxide solution (qs to pH 6.2); water for injections.

Contraindication

Hypersensitivity to methoxy polyethylene glycol-epoetin beta or to any of the excipients of the drug; uncontrolled arterial hypertension.

Method of application

Treatment with Mircera should be supervised by a physician experienced in the treatment of patients with renal insufficiency.

Mircera can be administered subcutaneously or intravenously. Mircera is administered subcutaneously in the abdomen, upper arm, or thigh. These sites are equally suitable for subcutaneous administration.

Application features

Pregnant women

Mircera should be used with caution in pregnant women.

Children

Treatment with Mircera is not recommended for children (under 18 years of age) due to the lack of data on the efficacy and safety of the drug.

Drivers

The drug has no or negligible influence on the ability to drive and use machines.

Overdose

Mircera has a wide therapeutic range. When initiating therapy, individual response to therapy should be taken into account. Overdose may lead to an increase in the pharmacodynamic effect, i.e. excessive erythropoiesis. In case of excessive increase in hemoglobin levels, Mircera treatment should be temporarily discontinued. Phlebotomy may be recommended if clinically indicated.

Side effects

When using Mircera, adverse reactions may occur in approximately 6% of patients. The most common adverse reaction was arterial hypertension (common adverse reaction).

Interaction

In the absence of compatibility studies, Mircera should not be mixed with other drugs.

Storage conditions

Store in the original packaging to protect from light at a temperature of 2°C to 8°C, out of the reach of children. Do not freeze.

The product can be removed from the refrigerator and stored at room temperature (not above 30°C) for a single use. The product should be used within this period, which should not exceed 1 month.

Shelf life - 3 years.

Specifications
Characteristics
Active ingredient
Methoxy polyethylene glycol-epoetin beta
ATC code
B AGENTS AFFECTING THE BLOOD SYSTEM AND HEMOPOIESIS; B03 ANTIANEMIQUE AGENTS; B03X OTHER ANTIANEMIQUE PREPARATIONS; B03X A Other antianemic preparations; B03X A03 Methoxypolyethylene glycol-epoetin beta
Country of manufacture
Germany
Dosage
75 mcg
Form
Pre-filled syringes
Method of application
Injections
Producer
Roche
Quantity per package
1 syringe
Trade name
Myrcera
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
Tribulus Nimbus capsules No. 60
In stock
0
1 485.60 грн.
new
Syringe 10 ml injection 1 needle g21
In stock
0
12.76 грн.
new
new
Sedaselfarm capsules 0.4 g No. 30
In stock
0
115.72 грн.
new
Syringe Injekt 2 ml g23 needle 0.6 x 30 No. 1
In stock
0
13.92 грн.
new
Certofix mono catheterization set
In stock
0
979.86 грн.
new
Sold out
Sodium chloride 0.9% 5 ml No. 10
Распродано
0
118.20 грн.
new
Sold out
Pregnancy test Family strip
Распродано
0
14.60 грн.
new
Indole-3-carbinol OS capsules 0.4 g No. 60
In stock
0
900.53 грн.
new
Intravenous cannula type Ultraflon with injection port G18
In stock
0
26.12 грн.